AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Two-channel IV-PCA With Dexmedetomidine

RecruitingNAAges 20 Years - anyAllKorea University Guro Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Dexmedetomidine was administered in the 'selector' channel and fentanyl in the 'basic \& bolus' channel of dual channel intravenous patient-controlled analgesia (IV-PCA) and the amount of opioid consumption was compared. In addition, intensity of pain, postoperative nausea/vomiting, and postoperative delirium was evaluated.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients who was scheduled for laparoscopic major abdominal surgery (Gastrectomy, Hepatectomy, Colectomy, Pancreatectomy) under general anesthesia * Aged โ‰ฅ 20 years old Exclusion Criteria: * Body mass index โ‰ฅ35 kg/m2 * American Society of Anesthesiologists physical status \> 3 * Severe cardiovascular disorder * Severe liver or renal dysfunction * Preoperative dyspnea * Contraindication to dexmedetomidine (preoperative severe bradycardia (Heart rate \<50), atrioventricular block, allergy to dexmedetomidine) * Preoperative use of opioid, anticonvulsant, antidepressant
๐Ÿ’Š

What it tests

  • Dexmedetomidine
  • Control
๐Ÿ“

Where

1 site
Korea University Guro Hospital
Seoul, South Korea
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy